Leading the Way in Life Science Technologies

GEN Exclusives

More »

Companies

More »

Updated: May 8 2012

Swift Biosciences

  • Swift Biosciences
  • 58 Parkland Plaza
  • Suite 100
  • Ann Arbor, MI, 48103
  • UNITED STATES

Swift Biosciences makes products that detect genes and gene products and also helps users analyze samples. Swift Biosciences opened its doors in February 2010 and launched the first retail product in its myT™ Primers platform—myT™ BRAF—for detection of BRAF mutations in February of 2012.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »